Rhelion Life Sciences Corp (RHEL.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 96 | 15 | 0 | 0 | 0 |
| Cost of Goods | 80 | 11 | N/A | N/A | N/A |
| Gross Profit | 15 | 4 | N/A | N/A | N/A |
| Operating Expenses | 1,548 | 936 | 832 | 1,494 | 306 |
| Operating Income | -1,533 | -932 | -832 | -1,494 | -306 |
| Interest Expense | 7 | 2 | 2 | N/A | N/A |
| Other Income | 758 | 1,108 | 338 | 640 | 0 |
| Pre-tax Income | -781 | 173 | -496 | -854 | -306 |
| Net Income Continuous | -781 | 173 | -496 | -854 | -306 |
| Net Income | $-781 | $173 | $-496 | $-854 | $-306 |
| EPS Basic Total Ops | -0.01 | 0.00 | 0.00 | -0.01 | 0.00 |
| EPS Basic Continuous Ops | -0.01 | 0.00 | 0.00 | -0.01 | N/A |
| EPS Diluted Total Ops | -0.01 | 0.00 | 0.00 | -0.01 | 0.00 |
| EPS Diluted Continuous Ops | -0.01 | 0.00 | 0.00 | -0.01 | N/A |
| EBITDA(a) | $-756 | $189 | $-491 | $-1,494 | $-306 |